Refine by
Antigen Avidity Suppliers Serving Tuvalu
4 companies found
based inPalo Alto, CALIFORNIA (USA)
Nirmidas Biotech was founded in September of 2013. We are a member of the Janssen Labs (JLABS) and QB3 programs, the Stanford StartX Med Program, and the MIT Industrial Liaison Program (MIT ILP). We are also a StartX Med COVID-19 Task Force Company ...
The test can be used for a variety of samples including serum, plasma, whole blood, dry blood spot, and saliva in a lab facility. It can be used to assess IgG and IgM levels in a sample with 100% sensitivity and 99.87% specificity without ...
based inBeaverton, OREGON (USA)
Sedia Biosciences is a privately held Delaware-registered medical device and diagnostics company founded in 2009 and based in Beaverton, Oregon, USA. Our commitment is to become a leader in three areas intended to advance global access to care: ...
An in vitro single well quantitative limiting antigen avidity enzyme immunoassay for distinguishing recent HIV-1 infections from those which are long-term. Intended for use with liquid serum or plasma specimens. ...
based inOxford, UNITED KINGDOM
Scancell is a clinical stage biopharmaceutical company that is leveraging its proprietary research, built up over many years of studying the human adaptive immune system, to generate truly novel medicines to treat significant unmet needs in cancer ...
ImmunoBody vaccines are designed to generate potent T cell responses capable of a broad anti-tumour effect. They are DNA vaccines that encode a protein in the form of an antibody, but the parts of the antibody that would normally bind to the target ...
based inRockville, MARYLAND (USA)
Founded in 2005, Maxim Biomedical (MaximBio) is a leading diagnostic healthcare company enhancing global health through the development and manufacture of trusted diagnostic solutions. Our mission is to create diagnostic products that are ...
The Maxim HIV-1 Limiting Antigen-Avidity Dried Blood Spot (DBS) EIA is an in-vitro quantitative limiting antigen (LAg) avidity enzyme immunoassay for distinguishing recent HIV-1 ...